User profiles for D. Mathew

Douglas B Matthews

- Verified email at uwec.edu - Cited by 7389

Divij Mathew

- Verified email at pennmedicine.upenn.edu - Cited by 7007

Microbial melanin: Recent advances in biosynthesis, extraction, characterization, and applications

S Singh, SB Nimse, DE Mathew, A Dhimmar… - Biotechnology …, 2021 - Elsevier
Melanin is a common name for a group of biopolymers with the dominance of potential
applications in medical sciences, cosmeceutical, bioremediation, and bioelectronic applications. …

An overview of the structure and magnetism of spinel ferrite nanoparticles and their synthesis in microemulsions

DS Mathew, RS Juang - Chemical engineering journal, 2007 - Elsevier
… It was found that the coercivity H c increases with decreasing grain size D down to values
of about 40 nm, independent of the kind of material. The increase of H c is proportional to 1/D. …

Viologens: a versatile organic molecule for energy storage applications

…, N Angulakshmi, DE Mathew, D Sujatha… - Journal of Materials …, 2021 - pubs.rsc.org
… Deepa Elizabeth Mathew has completed her post-graduate work in Chemistry from Loyola
College, Chennai, India and is currently pursuing her PhD under the supervision of Prof. A …

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

D Mathew, JR Giles, AE Baxter, DA Oldridge… - Science, 2020 - science.org
INTRODUCTION Many patients with coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, present with severe …

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

RR Goel, MM Painter, SA Apostolidis, D Mathew… - Science, 2021 - science.org
INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA
vaccines are highly effective at preventing infection and especially severe disease. However, …

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination

RR Goel, SA Apostolidis, MM Painter, D Mathew… - Science …, 2021 - science.org
mRNA vaccines for SARS-CoV-2 have been authorized for emergency use. Despite their
efficacy in clinical trials, data on mRNA vaccine–induced immune responses are mostly limited …

[HTML][HTML] Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

…, M Kakara, MM Painter, RR Goel, D Mathew… - Nature medicine, 2021 - nature.com
… (T1), 10–12 d after the first vaccine dose (T2), immediately before the second vaccine dose
(T3), 10–12 d after the second vaccine dose (T4) and 25–30 d after the second vaccine dose (…

[PDF][PDF] Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination

MM Painter, D Mathew, RR Goel, SA Apostolidis… - Immunity, 2021 - cell.com
SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions
remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific …

[HTML][HTML] CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

…, S Tollett, C Wright, T Perloff, L Sun, D Mathew… - Nature medicine, 2021 - nature.com
Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and
the immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …

[PDF][PDF] Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

…, TB Manzoni, O Oniyide, H Ramage, D Mathew… - Cell, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within
the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had been …